West Pharmaceutical Services | WST - Loan Capital

Stock Price
296.93
Daily Change
-5.27 -1.74%
Monthly
21.13%
Yearly
37.39%
Q2 Forecast
299.61

West Pharmaceutical Services reported $202.8M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Align Technology USD 0 0 Dec/2024
Avanos Medical USD 90.3M 3.1M Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Cerus USD 64.86M 22K Dec/2024
Charles River Laboratories USD 2.14B 49.09M Dec/2025
Cooper Companies USD 1.88B 578.5M Dec/2025
Dentsply International USD 2.02B 2M Dec/2025
Haemonetics USD 919.99M 406K Dec/2025
ICU Medical USD 1.27B 48.01M Dec/2025
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Merit Medical Systems USD 734.04M 1.12M Dec/2025
Neogen USD 793.3M 374K Dec/2025
OraSure Technologies USD 100K 17K Dec/2025
Quidel USD 2.47B 2.47B Dec/2025
Repligen USD 542.21M 4.29M Dec/2025
Rockwell Medical USD 8.65M 89K Jun/2025
Solventum Corp USD 5.04B 102M Dec/2025
STAAR Surgical USD 42K 42K Dec/2023
Terumo JPY 99.9B 12M Dec/2025
Utah Medical Products USD 0 0 Mar/2022
West Pharmaceutical Services USD 202.8M 0 Mar/2026